14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Aug 08, 2022 $0.0112 $0.0135 $0.0108 $0.0114 572 381
Aug 05, 2022 $0.0101 $0.0118 $0.0100 $0.0111 208 604
Aug 04, 2022 $0.0100 $0.0130 $0.0100 $0.0105 214 717
Aug 03, 2022 $0.0102 $0.0120 $0.0097 $0.0101 548 989
Aug 02, 2022 $0.0108 $0.0108 $0.0097 $0.0108 604 402
Aug 01, 2022 $0.0112 $0.0129 $0.0095 $0.0100 3 417 791
Jul 29, 2022 $0.0120 $0.0132 $0.0112 $0.0112 185 094
Jul 28, 2022 $0.0129 $0.0139 $0.0119 $0.0120 489 895
Jul 27, 2022 $0.0122 $0.0131 $0.0122 $0.0130 727 620
Jul 26, 2022 $0.0120 $0.0132 $0.0112 $0.0123 315 753
Jul 25, 2022 $0.0120 $0.0140 $0.0110 $0.0126 640 715
Jul 22, 2022 $0.0129 $0.0140 $0.0114 $0.0120 478 267
Jul 21, 2022 $0.0133 $0.0143 $0.0129 $0.0129 403 562
Jul 20, 2022 $0.0155 $0.0155 $0.0123 $0.0138 673 760
Jul 19, 2022 $0.0152 $0.0161 $0.0131 $0.0155 400 069
Jul 18, 2022 $0.0135 $0.0163 $0.0110 $0.0163 533 652
Jul 15, 2022 $0.0138 $0.0150 $0.0105 $0.0150 1 236 423
Jul 14, 2022 $0.0138 $0.0149 $0.0135 $0.0149 393 151
Jul 13, 2022 $0.0136 $0.0166 $0.0127 $0.0138 737 691
Jul 12, 2022 $0.0150 $0.0169 $0.0133 $0.0140 594 729
Jul 11, 2022 $0.0132 $0.0150 $0.0132 $0.0145 486 485
Jul 08, 2022 $0.0122 $0.0148 $0.0122 $0.0140 1 397 615
Jul 07, 2022 $0.0150 $0.0160 $0.0140 $0.0141 1 218 805
Jul 06, 2022 $0.0150 $0.0166 $0.0135 $0.0159 1 867 248
Jul 05, 2022 $0.0150 $0.0166 $0.0150 $0.0159 83 513
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT